KIMBERLY CLARK CORP KMB revenue by segment, product and geography
In its fiscal year ending 2025-12-31, KIMBERLY CLARK CORP reported revenue across 6 products and services; the largest, Babyandchildcareproducts, was $6.77B, 41.2% of the filed sum (-4.0% against the prior period in the same filing).
Reported segment mix
figures as filed · share of the filed sum · change vs the prior period in the same filing- Babyandchildcareproducts$6.77B41.2%-4.0% yoy
- Family Care$4.06B24.7%+3.3% yoy
- Adult Care Products$1.95B11.8%+4.5% yoy
- Professional$1.84B11.2%-14.5% yoy
- Feminine Care Products$1.71B10.4%-0.9% yoy
- All Other$124M0.8%+47.6% yoy
Members sum to the consolidated $16.4B for this period.
- United States$10.1B100.0%-2.9% yoy
Members sum to $10.1B against $16.4B consolidated (residual $6.35B) - eliminations or corporate lines the filer did not tag on this axis.
- Babyandchildcareproducts$1.7B40.7%+3.6% yoy
- Family Care$1.04B25.0%+1.3% yoy
- Adult Care Products$483M11.6%+1.5% yoy
- Professional Products$460M11.0%+3.1% yoy
- Feminine Care Products$451M10.8%+1.8% yoy
- All Other$33M0.8%+32.0% yoy
Change is against the same quarter a year earlier, as reported in the same 10-Q.
Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.
About these figures
Companies tag segment, product and geographic revenue as dimensional XBRL facts in their 10-K and 10-Q filings. The SEC publishes those facts in its DERA Financial Statement and Notes data sets; TrendNalysis ingests each monthly file and serves the facts exactly as filed, keyed to the accession of the filing. Shares are of the filed sum. Where a filer tags more than one breakdown on one axis, the sum exceeds consolidated revenue and no shares are computed; where the members do not add up to the consolidated figure, the residual is stated rather than hidden. Missing is never zero.
Descriptive and educational; not investment advice. Methodology and data lineage.